ENG/中
老虎证券
市场
行情
24/7新闻
产品
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
港股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
生物医药B类股
432.705
-14.664
-3.28%
手动刷新
涨家数:
6
跌家数:
24
平家数:
3
市盈率:
- -
高:
446.899
开:
446.899
低:
429.612
收:
447.369
成交量:
5,337.17万
成交额:
13.25亿
市值:
2,789.27亿
流通市值:
2,486.06亿
数据加载中...
总览
新闻资讯
翰森制药(03692)已上市创新药所有获批适应症均已纳入医保目录
智通财经
·
2小时前
药明巨诺-B(02126.HK):倍诺达® (瑞基奥仑赛注射液)纳入国家基本医保药品目录
智通财经
·
2小时前
远大医药(00512)六款产品成功纳入 2026 年国家医保药品目录、商保创新药目录及行业配套清单
智通财经
·
2小时前
远大医药(00512.HK)六款产品成功纳入 2026 年国家医保药品目录、商保创新药目录及行业配套清单
智通财经
·
2小时前
华东医药(000963.SZ):产品及合作产品纳入国家医保目录及商保创新药目录
智通财经
·
3小时前
诺诚健华(688428.SH):佐来曲替尼片纳入2026年国家医保目录
智通财经
·
3小时前
诺诚健华:佐来曲替尼纳入2026年国家医保目录
格隆汇
·
3小时前
重磅创新药进入医保!复星医药6款药品迎来医保身份升级,覆盖首次纳入、适应症扩容
深圳商报·读创
·
4小时前
A股多家医药企业集中披露,公司旗下药品纳入国家医药目录
中新经纬
·
4小时前
百万CAR-T进医保之后:商保转基本医保通道打开,放量验证才刚开始
同花顺
·
4小时前
医保目录扩容背后:创新药准入的闸门正在换一种开法
同花顺
·
4小时前
商保药品推荐清单如何推动高价创新药可及性?行业人士解读
每日经济新闻
·
5小时前
创新药数量创新高!百万元一针的CAR-T首次纳入,新版医保药品目录有哪些变化?
每日经济新闻
·
6小时前
脑卒中创新药先必新®舌下片首次纳入基本医保目录
新浪科技
·
7小时前
2026年版国家医保药品目录公布:51个1类新药、首例CAR-T入保、“预申报”落地
蓝鲸财经
·
10小时前
击穿百万价格后,首批转目录的创新药销量能大爆发吗?
第一财经
·
11小时前
新闻周刊丨创新药进院难在哪?如何打通“最后一公里”?
央视
·
18小时前
商保创新药目录扩容至28种:如何让更多患者用上高价创新药?
每日经济新闻
·
昨天
新版医保目录新增51个一类新药,CAR-T首进,还有哪些亮点?
澎湃新闻
·
昨天
亚盛医药利生妥®成功纳入2026年国家医保药品目录,耐立克®续约
美通社
·
昨天
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/BK1574/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物医药B类股","latestPrice":432.7054,"timestamp":1794557295263,"preClose":447.36902,"halted":0,"volume":53371670,"delay":0,"changeRate":-0.032777,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-14.663605,"latestTime":"11-13 16:00:00","open":446.8992,"high":446.8992,"low":429.61166,"amount":1325489079.5,"amplitude":0.038643,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794792600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1794533400000,1794542400000],[1794546000000,1794556800000]],"pbRate":3.191364,"peRate":89.597205,"turnoverRate":0.001985,"increases":7,"decrements":24,"flats":1,"marketCap":278927212400,"floatMarketCap":248606026976},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":446.8992,"amplitude":0.038643,"preClose":447.36902,"low":429.61166,"pbRate":"3.191364","latestPrice":432.7054,"volume":53371670,"delay":0,"open":446.8992,"prevYearClose":556.26263,"prevWeekClose":441.249,"prevMonthClose":422.244,"prevQuarterClose":532.388,"fiveDayClose":441.249,"twentyDayClose":455.098,"sixtyDayClose":492.831,"secType":"PLATE","market":"HK","turnoverRate":0.001985,"peRate":89.597205,"marketCap":278927212400,"floatMarketCap":248606026976,"timestamp":1794557295263,"nameCN":"生物医药B类股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":6,"down":24,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2683659954","title":"翰森制药(03692)已上市创新药所有获批适应症均已纳入医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2683659954","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683659954?lang=zh_cn&edition=fundamental","pubTime":"2026-11-15 18:45","pubTimestamp":1794739531,"startTime":"0","endTime":"0","summary":"智通财经APP讯,翰森制药 公布,集团创新药阿美乐新增一项适应症、昕越新增两项适应症成功纳入新版《国家基本医疗保险、工伤保险和生育保险药品目录》,新版国家目录将于2027年1月1日正式实施。集团已上市创新药所有获批适应症均已纳入医保目录,有助于进一步提高各创新药在患者中的可负担性和可及性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1523332.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1589","BK1161","MEDX","IBBQ","IPOS","BK1191","BK1583","BK1574","03692","06978","LNGR","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683659314","title":"药明巨诺-B(02126.HK):倍诺达® (瑞基奥仑赛注射液)纳入国家基本医保药品目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2683659314","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683659314?lang=zh_cn&edition=fundamental","pubTime":"2026-11-15 18:25","pubTimestamp":1794738305,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","BK1574","BK1161","02126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683855659","title":"远大医药(00512)六款产品成功纳入 2026 年国家医保药品目录、商保创新药目录及行业配套清单","url":"https://stock-news.laohu8.com/highlight/detail?id=2683855659","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683855659?lang=zh_cn&edition=fundamental","pubTime":"2026-11-15 18:09","pubTimestamp":1794737396,"startTime":"0","endTime":"0","summary":"智通财经APP讯,远大医药 公布,近日,集团共有六款产品成功纳入由中华人民共和国国家医疗保障局发布的《国家基本医疗保险、生育保险和工伤保险药品目录》 《商业健康保险创新药品目录》、中国保险行业协会发布的《商业健康保险药品保障推荐清单(第一版)》或中国精算师协会发布的《商业健康保险保障成本测算涉及药品》。集团相信,医保与商保的协同联动,是国家“保基本、促创新”、大力支援创新药高质量发展的重要举措。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1523317.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","159992","BK1191","BK1574","MEDX","00512","LNGR","06978","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683665985","title":"远大医药(00512.HK)六款产品成功纳入 2026 年国家医保药品目录、商保创新药目录及行业配套清单","url":"https://stock-news.laohu8.com/highlight/detail?id=2683665985","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683665985?lang=zh_cn&edition=fundamental","pubTime":"2026-11-15 18:09","pubTimestamp":1794737396,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["00512","BK1191","BK1161","06978","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683656765","title":"华东医药(000963.SZ):产品及合作产品纳入国家医保目录及商保创新药目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2683656765","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683656765?lang=zh_cn&edition=fundamental","pubTime":"2026-11-15 17:49","pubTimestamp":1794736167,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华东医药(000963.SZ)发布公告,公司部分产品及合作产品被纳入新版药品目录及新版商保创新药目录。公司全资子公司杭州中美华东制药有限公司马来酸美凡厄替尼片被纳入协议期内谈判药品部分;合作产品脯氨酸加格列净片完成续约,支付标准与支付范围不变;他克莫司颗粒调整至常规目录管理,支付范围较前一版药品目录没有变动;合作产品泽沃基奥仑赛注射液继续被纳入新版商保创新药目录。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1523313.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0209","BK1161","BK0175","BK0187","000963","159992","BK0183","BK0132","IBBQ","LU1969619763.USD","LU2328871848.SGD","BK0196","BK0188","BK1574","MEDX","06978","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683566666","title":"诺诚健华(688428.SH):佐来曲替尼片纳入2026年国家医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2683566666","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683566666?lang=zh_cn&edition=fundamental","pubTime":"2026-11-15 17:03","pubTimestamp":1794733381,"startTime":"0","endTime":"0","summary":"智通财经APP讯,诺诚健华(688428.SH)发布公告,公司自主研发的新一代TRK抑制剂佐来曲替尼片(商品名:宜诺欣®)被纳入新版国家医保目录,用于治疗携带NTRK融合基因的成人和12岁以上青少年实体瘤患者。新版国家医保目录将自2027年1月1日起正式实施。协议有效期为2027年1月1日至2028年12月31日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1523306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK1161","BK1574","688428","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683656366","title":"诺诚健华:佐来曲替尼纳入2026年国家医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2683656366","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683656366?lang=zh_cn&edition=fundamental","pubTime":"2026-11-15 16:53","pubTimestamp":1794732816,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["09969","BK1574","688428","BK1161","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683656266","title":"重磅创新药进入医保!复星医药6款药品迎来医保身份升级,覆盖首次纳入、适应症扩容","url":"https://stock-news.laohu8.com/highlight/detail?id=2683656266","media":"深圳商报·读创","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683656266?lang=zh_cn&edition=fundamental","pubTime":"2026-11-15 16:40","pubTimestamp":1794732053,"startTime":"0","endTime":"0","summary":"深圳商报·读创客户端记者穆砚11月15日,上海复星医药(集团)股份有限公司(以下简称“复星医药”或“公司”)发布关于控股子公司药品获新纳入国家医保目录的提示性公告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611153931459076.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611153931459076.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06978","BK0060","02196","600196","BK1574","BK0183","BK1515","BK0012","159992","BK1191","BK1593","LNGR","BK0196","BK1161","BK0187","MEDX","IBBQ","BK0175","BK0028","BK0188","BK0096","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683656116","title":"A股多家医药企业集中披露,公司旗下药品纳入国家医药目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2683656116","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683656116?lang=zh_cn&edition=fundamental","pubTime":"2026-11-15 16:37","pubTimestamp":1794731846,"startTime":"0","endTime":"0","summary":"15日,多家A股上市医药企业公告称,公司相关药品续约或纳入2026年版国家医保目录。微芯生物公告称,公司产品西格列他钠片(双洛平?)成功续约《国家医保目录》,药品分类为乙类,协议有效期为2027年1月1日至2028年12月31日。西格列他钠是公司独家发现的全球首个获批上市的PPAR全激动剂,用于治疗2型糖尿病,2023年首次纳入国家医保目录。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611153931457172.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611153931457172.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02827","BK1161","03188","BK1515","83188","02843","82823","82843","159982","07233","BK1574","09939","02823","BK1610","BK1147","02822","159938","83130","03130","82822","02846","399300","82846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683656838","title":"百万CAR-T进医保之后:商保转基本医保通道打开,放量验证才刚开始","url":"https://stock-news.laohu8.com/highlight/detail?id=2683656838","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683656838?lang=zh_cn&edition=fundamental","pubTime":"2026-11-15 16:26","pubTimestamp":1794731160,"startTime":"0","endTime":"0","summary":"药明巨诺的瑞基奥仑赛注射液进入基本医保目录的消息,让一位资深医药人士在11月14日难掩激动。他的判断很直接:这款CAR-T细胞药物明年销量会大涨。瑞基奥仑赛由此成为继诺西那生钠之后,又 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261115/c681829667.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261115/c681829667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK1161","MEDX","06978","LNGR","BK1574","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683656833","title":"医保目录扩容背后:创新药准入的闸门正在换一种开法","url":"https://stock-news.laohu8.com/highlight/detail?id=2683656833","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683656833?lang=zh_cn&edition=fundamental","pubTime":"2026-11-15 16:24","pubTimestamp":1794731040,"startTime":"0","endTime":"0","summary":"11月14日,2026年国家医保药品目录与商业健康保险创新药品目录在苏州公布。新版基本医保目录新增107种药品,其中1类创新药51个,数量创历史新高;目录药品总数达到3331个,西药1935个、中成 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261115/c681829671.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261115/c681829671.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LNGR","BK1161","159992","06978","IBBQ","BK1574","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683165533","title":"商保药品推荐清单如何推动高价创新药可及性?行业人士解读","url":"https://stock-news.laohu8.com/highlight/detail?id=2683165533","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683165533?lang=zh_cn&edition=fundamental","pubTime":"2026-11-15 15:07","pubTimestamp":1794726452,"startTime":"0","endTime":"0","summary":"近日,中国保险行业协会(以下简称中保协)正式发布三份商业医疗保险示范条款及《商业健康保险药品保障推荐清单(第一版)》(下称“商保药品推荐清单”)。其中,商保药品推荐清单作为医疗险示范条款的重要组成部分,适用于院外特定药械责任,与短期、长期两款一般商业医疗保险示范条款配套使用。长期以来,创新药商业化面临“基本医保门槛高、商业保险量太小”的双重困境。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://insurance.eastmoney.com/a/202611153931422724.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://insurance.eastmoney.com/a/202611153931422724.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06978","MEDX","IBBQ","LNGR","BK1161","BK1574","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683653204","title":"创新药数量创新高!百万元一针的CAR-T首次纳入,新版医保药品目录有哪些变化?","url":"https://stock-news.laohu8.com/highlight/detail?id=2683653204","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683653204?lang=zh_cn&edition=fundamental","pubTime":"2026-11-15 14:37","pubTimestamp":1794724636,"startTime":"0","endTime":"0","summary":"11月14日,2026年创新药高质量发展大会在苏州金鸡湖国际会议中心召开。《每日经济新闻》记者(以下简称每经记者)在现场获悉,2026年《国家基本医疗保险、生育保险和工伤保险药品目录》(以下简称“医保目录”)以及《商业健康保险创新药品目录》(以下简称“商保创新药目录”)正式公布。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611153931421676.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611153931421676.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","MEDX","IBBQ","BK1574","06978","LNGR","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683658492","title":"脑卒中创新药先必新®舌下片首次纳入基本医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2683658492","media":"新浪科技","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683658492?lang=zh_cn&edition=fundamental","pubTime":"2026-11-15 12:57","pubTimestamp":1794718620,"startTime":"0","endTime":"0","summary":"脑卒中素有高发病、高致残的特点,其中急性缺血性卒中占全部卒中的85%以上。在临床应用场景上,先必新注射液与舌下片形成互补与接力。先必新注射液主要聚焦于医院内的急性期规范治疗,为院内抢救提供强有力的支持;而先必新舌下片则凭借独特的舌下速崩剂型,将治疗场景成功拓展到了出院与居家康复。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tech/shenji/2026-11-15/doc-iniyuuaf2103793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","159992","BK1161","LNGR","IBBQ","06978","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683637717","title":"2026年版国家医保药品目录公布:51个1类新药、首例CAR-T入保、“预申报”落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2683637717","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683637717?lang=zh_cn&edition=fundamental","pubTime":"2026-11-15 10:09","pubTimestamp":1794708581,"startTime":"0","endTime":"0","summary":"新版国家医保药品目录新增107种药品,其中51个一类新药,再创历史新高。此次调整后,2026年版国家医保药品目录药品总数达到3331个,其中西药1935个、中成药1396个。此外,商业健康保险创新药品目录同步调整,新增12种药品;调整后,2026年商业健康保险创新药品目录共有28种。两个目录将于2027年1月1日正式执行。2026年首次允许已完成技术审评、但尚未拿到正式批件的药品提前预申报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1794708540205267972","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LNGR","BK1574","IBBQ","MEDX","BK1161","06978","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683375086","title":"击穿百万价格后,首批转目录的创新药销量能大爆发吗?","url":"https://stock-news.laohu8.com/highlight/detail?id=2683375086","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683375086?lang=zh_cn&edition=fundamental","pubTime":"2026-11-15 09:01","pubTimestamp":1794704460,"startTime":"0","endTime":"0","summary":"“创新药要爆发了,这款CAR-T明年销量会大涨!”这成为我国医保谈判历史上又一标志性事件,表明商保目录药品转入基本医保的通道正式打通。黄心宇表示,今年共有7个药品提出申请,最终成功2个。价格是高值创新药进入基本医保最重要的条件。国家医保局医药价格和招标采购指导中心主任丁一磊在政策解读活动中表示,医保准入是创新药商业化的关键放大器。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-11-15/doc-iniyupue9788616.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-11-15/doc-iniyupue9788616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","BK1574","IBBQ","MEDX","BK1161","06978","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683632828","title":"新闻周刊丨创新药进院难在哪?如何打通“最后一公里”?","url":"https://stock-news.laohu8.com/highlight/detail?id=2683632828","media":"央视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683632828?lang=zh_cn&edition=fundamental","pubTime":"2026-11-15 01:54","pubTimestamp":1794678840,"startTime":"0","endTime":"0","summary":"长期以来,创新药即使进入医保,仍需经医院药事委员会审核等层层环节才能进入医院。本周二,国家卫健委等四部门联合印发《关于进一步做好创新药安全合理配备使用工作的通知》,提出要从四个方面直面这些体制机制障碍,为创新药第一时间抵达患者手中提速。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-11-15/doc-iniytwwr2437582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","MEDX","IBBQ","LNGR","BK1161","BK1574","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683636427","title":"商保创新药目录扩容至28种:如何让更多患者用上高价创新药?","url":"https://stock-news.laohu8.com/highlight/detail?id=2683636427","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683636427?lang=zh_cn&edition=fundamental","pubTime":"2026-11-14 22:47","pubTimestamp":1794667655,"startTime":"0","endTime":"0","summary":"11月14日,2026年商业健康保险创新药品目录公布,此次共有11家企业的12种药品新增纳入。调整后,2026年商业健康保险创新药品目录共有28种。《每日经济新闻》记者(以下简称每经记者)注意到,新增的创新药中,既包括本土企业研发的全球首个实体瘤CAR-T、中国首个血友病基因治疗药物等创新药,还包括多个跨国药企的创新产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://insurance.eastmoney.com/a/202611143931377614.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://insurance.eastmoney.com/a/202611143931377614.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","MEDX","06978","159992","LNGR","IBBQ","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683356586","title":"新版医保目录新增51个一类新药,CAR-T首进,还有哪些亮点?","url":"https://stock-news.laohu8.com/highlight/detail?id=2683356586","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683356586?lang=zh_cn&edition=fundamental","pubTime":"2026-11-14 19:54","pubTimestamp":1794657259,"startTime":"0","endTime":"0","summary":"11月14日,2026创新药高质量发展大会在苏州举办,2026版基本医保药品目录和创新药目录(简称“双目录”)也在本次大会正式发布。尽管苏州的天气是阴沉的,大会现场气氛却十分热烈。澎湃新闻记者注意到,大会安排了超过1500个的座位,座无虚席,也有不少参会者选择站着听会。根据国家医保局发布的消息,基本医保目录新增107种药品,其中51个一类新药,再创历史新高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611143931362664.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611143931362664.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4022","BK1161","ADC","MEDX","NETL","BK4230","CD","BK4080","BK4195","BK4023","PFS","BK1574","BK4116","BK4211","UCB","CAR","BK4231","LNGR","IBBQ","06978","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683636613","title":"亚盛医药利生妥®成功纳入2026年国家医保药品目录,耐立克®续约","url":"https://stock-news.laohu8.com/highlight/detail?id=2683636613","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683636613?lang=zh_cn&edition=fundamental","pubTime":"2026-11-14 18:12","pubTimestamp":1794651120,"startTime":"0","endTime":"0","summary":"截至目前,亚盛医药两款高质量全球创新药的全部获批适应症均已纳入国家医保药品目录,将为更多患者提供更加可及的创新治疗选择。利生妥于2025年7月在中国获批上市,是中国首个上市的国产原创Bcl-2抑制剂。此次利生妥成功纳入新版国家医保药品目录,将大大提升国内CLL/SLL患者的用药可及性,让更多患者能够及时获得新的治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"https://www.prnasia.com/story/archive/5097943_ZH97943_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnasia.com/story/archive/5097943_ZH97943_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["06855","BK4139","AAPG","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":1,"totalSize":388,"code":"91000000","status":"200"}]}}